Post by Bruker BioSpin

Our first SPECT CUBE has been in the field for 10 years. In that time, the needs of preclinical SPECT imaging evolved. Theranostics research requires reliable imaging of high-energy radionuclides. The classical compromise between sensitivity, resolution, and field of view is under pressure. Our engineers took on these challenges and built a system capable of imaging therapeutic radionuclides and detecting subtle biological signals with high sensitivity, without missing out on spatial resolution. The result is new, patent-pending hardware that meets the needs of modern SPECT research. It's the most confident theranostic imaging system we've built. Meet our new γ-CUBE: https://lnkd.in/eyuHMn35 #SPECT #Theranostics #MolecularImaging